Despite their potential, ribozymes face several challenges:
Stability: RNA molecules are generally less stable than proteins, making ribozymes more susceptible to degradation. Efficiency: Some ribozymes have lower catalytic efficiencies compared to protein enzymes, limiting their practical applications. Delivery: In therapeutic applications, delivering ribozymes to target cells and ensuring their proper function remains a significant hurdle.
